News Conference News ESC 2022 Factor XIa Inhibitors Show Potential for Safer Anticoagulation After MI, Stroke Todd Neale August 28, 2022
News Opinion Editor's Corner ESC 2022 What’s Going to Be Hot at ESC 2022? Shelley Wood August 22, 2022
News Features Novel Targets, Gene Edits, and Vaccines: Is a ‘Golden Era’ Dawning for ASCVD? Michael O'Riordan August 15, 2022
News Daily News AHA, CRF Announce Partnership for 2022 Fall Meeting Sessions Shelley Wood August 15, 2022
News Daily News Wearable Devices Are Cost-effective AF Screening Tools Caitlin E. Cox August 10, 2022
News Daily News Lp(a) Levels Linked to Aortic Valve Calcification, Not Progression Michael O'Riordan August 08, 2022
News Daily News Meat Consumption and Gut Microbiome Linked to ASCVD Risk Yael L. Maxwell August 03, 2022
News Daily News Dapagliflozin Safe, Effective in Diabetes Regardless of Background CV Meds Shelley Wood July 25, 2022
News Daily News AHA Registry IDs Social Vulnerability as Risk Factor for COVID-19 Death Caitlin E. Cox July 22, 2022
News Daily News Knowns, Unknowns of Vaccine Myocarditis Risks Summarized in ‘Living’ Review Shelley Wood July 21, 2022
News Daily News Increased Blood Viscosity Tied to Mortality in Hospitalized COVID-19 Patients Todd Neale July 18, 2022
News Daily News Political Leanings Found to Affect Mortality Rates Now More Than Ever L.A. McKeown June 17, 2022
News Conference News EAS 2022 Elevated Risks From Lp(a) Can Be Offset by Lower Lifetime LDL Cholesterol Michael O'Riordan May 26, 2022
News Conference News EAS 2022 Lp(a) Linked to ASCVD and Aortic Stenosis Regardless of CRP Level Michael O'Riordan May 24, 2022
News Conference News EAS 2022 ROSE Trial: CETP Inhibitor Shows Promise as Oral Add-on for LDL-Lowering Michael O'Riordan May 24, 2022